Crosstalk Between the Androgen Receptor and -Catenin in Castrate-Resistant Prostate Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-08-1718
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Regulation of the Transcriptional Coactivator FHL2 Licenses Activation of the Androgen Receptor in Castrate-Resistant Prostate Cancer

Cancer Research
Cancer ResearchOncology
2013English

The Link Between Androgen Receptor Splice Variants and Castration-Resistant Prostate Cancer

Hormones and Cancer
OncologyCancer ResearchEndocrinologyAutonomic SystemsEndocrineMetabolismDiabetes
2014English

The Pioneering Role of GATA2 in Androgen Receptor Variant Regulation Is Controlled by Bromodomain and Extraterminal Proteins in Castrate-Resistant Prostate Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

Evaluation of the Genomic Alterations in the Androgen Receptor Gene During Treatment With High-Dose Testosterone for Metastatic Castrate-Resistant Prostate Cancer

Oncotarget
Oncology
2020English

New Therapeutics to Treat Castrate-Resistant Prostate Cancer

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2013English

Guidelines for the Management of Castrate-Resistant Prostate Cancer

Journal of the Canadian Urological Association
OncologyUrology
2010English

Guidelines for the Management of Castrate-Resistant Prostate Cancer

Canadian Urological Association Journal
Urology
2013English

Interplay Between the Androgen Receptor Signalling Axis and microRNAs in Prostate Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2019English

Management of Docetaxel Failures in Metastatic Castrate-Resistant Prostate Cancer

Urologic Clinics of North America
Urology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy